Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma.
J Clin Oncol. 2018 Jul 1;36(19):1913-1921. doi: 10.1200/JCO.2017.76.0892. Epub 2018 Mar 2.
J Clin Oncol. 2018.
PMID: 29498924
Clinical Trial.
Single administration of Selective Internal Radiation Therapy versus continuous treatment with sorafeNIB in locally advanced hepatocellular carcinoma (SIRveNIB): study protocol for a phase iii randomized controlled trial.
Gandhi M, Choo SP, Thng CH, Tan SB, Low AS, Cheow PC, Goh AS, Tay KH, Lo RH, Goh BK, Wong JS, Ng DC, Soo KC, Liew WM, Chow PK; Asia-Pacific Hepatocellular Carcinoma Trials Group.
Gandhi M, et al. Among authors: liew wm.
BMC Cancer. 2016 Nov 7;16(1):856. doi: 10.1186/s12885-016-2868-y.
BMC Cancer. 2016.
PMID: 27821083
Free PMC article.
Clinical Trial.
Item in Clipboard
Polypharmacy and potentially inappropriate medications among hospitalized older adults with COVID-19 in Malaysian tertiary hospitals.
Chang CT, Mohd Shariff SM, Abu Bakar NS, Ramzuzzaman NS, Lim CK, Lim EYJ, Ong PS, Lee JM, Tan AY, Kamis SF, Liew WM, Low YM, George D, Voo JYH, Tan HS, Rajan P, Lee SWH.
Chang CT, et al. Among authors: liew wm.
J Pharm Policy Pract. 2023 Jan 12;16(1):2. doi: 10.1186/s40545-022-00504-1.
J Pharm Policy Pract. 2023.
PMID: 36635766
Free PMC article.
Item in Clipboard
Cite
Cite